MBX Biosciences, Inc. (MBX)
NASDAQ: MBX · Real-Time Price · USD
7.76
+0.35 (4.72%)
At close: Mar 28, 2025, 4:00 PM
7.55
-0.21 (-2.67%)
After-hours: Mar 28, 2025, 6:30 PM EDT

MBX Biosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022
Period Ending
Dec '24 Dec '23 Dec '22
Net Income
-61.92-32.56-26.14
Depreciation & Amortization
0.240.160.06
Loss (Gain) From Sale of Assets
-0.07-
Loss (Gain) From Sale of Investments
-2.93-1.04-0.03
Stock-Based Compensation
5.222.040.31
Other Operating Activities
0.110.11.39
Change in Accounts Payable
3.930.410.67
Change in Other Net Operating Assets
0.67-1.150.62
Operating Cash Flow
-54.68-31.98-23.12
Capital Expenditures
-0.87-0.13-0.44
Investment in Securities
-159.72-30.8-10.97
Investing Cash Flow
-160.6-30.93-11.41
Short-Term Debt Issued
--10
Total Debt Issued
--10
Net Debt Issued (Repaid)
--10
Issuance of Common Stock
174.950.740.03
Other Financing Activities
-4.34-0.03-0.46
Financing Cash Flow
234.169.2246.06
Net Cash Flow
18.836.3111.53
Free Cash Flow
-55.56-32.11-23.56
Free Cash Flow Per Share
-5.22-31.52-35.33
Levered Free Cash Flow
-33.27-20.56-
Unlevered Free Cash Flow
-33.27-20.56-
Change in Net Working Capital
-4.760.56-
Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q